{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:49:59Z","timestamp":1789897799925,"version":"4.0.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1093\/toxsci\/kfh109","type":"journal-article","created":{"date-parts":[[2004,4,6]],"date-time":"2004-04-06T00:23:50Z","timestamp":1081211030000},"page":"381-393","source":"Crossref","is-referenced-by-count":155,"title":["Evaluation of the Potential Impact of Age- and Gender-Specific Pharmacokinetic Differences on Tissue Dosimetry 2Current address: Novartis Pharmaceuticals, East Hanover, NJ 07936."],"prefix":"10.1093","volume":"79","author":[{"given":"Harvey J.","family":"Clewell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Robinan","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie R.","family":"Covington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Sarangapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin G.","family":"Teeguarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,6]]},"reference":[{"key":"key\n\t\t\t\t20170508185709_R1","doi-asserted-by":"crossref","unstructured":"Abraham, K., Knoll, A., Ende, M., Papke, O., and Helge, H. (1996). Intake, fecal excretion, and body burden of polychlorinated dibenzo-p-dioxins and dibenzofurans in breast-fed and formula-fed infants. Pediatr. Res.40(5), 671\u2013679.","DOI":"10.1203\/00006450-199611000-00005"},{"key":"key\n\t\t\t\t20170508185709_R2","doi-asserted-by":"crossref","unstructured":"Alcorn, J., and McNamara, P. J. (2003). Pharmacokinetics in the newborn. Adv. Drug Deliv. Rev.55,667\u2013686.","DOI":"10.1016\/S0169-409X(03)00030-9"},{"key":"key\n\t\t\t\t20170508185709_R3","unstructured":"Andersen, M. E., Gargas, M. L., Hays, S. M., Clewell, H. J., III, and Paustenbach, D. J. (1997). Estimating minimally effective inducing doses (ED01s) of TCDD in livers of rats and humans using physiologically based pharmacokinetic modeling. Organohalogen Compounds34,311\u2013316."},{"key":"key\n\t\t\t\t20170508185709_R4","doi-asserted-by":"crossref","unstructured":"Andersen, M., Clewell, H., Gargas, M., Smith, F., and Reitz, R. (1987). Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol.87(2), 185\u2013205.","DOI":"10.1016\/0041-008X(87)90281-X"},{"key":"key\n\t\t\t\t20170508185709_R5","unstructured":"A\u030astrand, I. (1983). Effect of physical exercise on uptake, distribution and elimination of vapors in man. In Modeling of Inhalation Exposure to Vapors: Uptake, Distribution, and Elimination (Fiserova-Bergerova V, Ed.), Vol. 2, pp. 107\u2013130. CRC Press, Boca Raton, FL."},{"key":"key\n\t\t\t\t20170508185709_R6","unstructured":"Braunlich, H. (1977). Kidney development: Drug elimination mechanisms. In Drug Disposition During Development (P. Morselli, Ed.), pp.89\u2013101. Spectrum Publications Inc., New York.)"},{"key":"key\n\t\t\t\t20170508185709_R7","doi-asserted-by":"crossref","unstructured":"Clewell, H. J., Gentry, P. R., Gearhart, J. M., Allen, B. C., and Andersen, M. E. (2001a). Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. Science of the Total Environment274(1\u20133), 37\u201366.","DOI":"10.1016\/S0048-9697(01)00730-6"},{"key":"key\n\t\t\t\t20170508185709_R8","doi-asserted-by":"crossref","unstructured":"Clewell, H. J., Gentry, P. R., Gearhart, J. M., Covington, T. R., Banton, M. I., and Andersen, M. E. (2001b). Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol. Sci.63,160\u2013172.","DOI":"10.1093\/toxsci\/63.2.160"},{"key":"key\n\t\t\t\t20170508185709_R9","doi-asserted-by":"crossref","unstructured":"Clewell, H., Teeguarden, J., McDonald, T., Sarangapani, R., Lawrence, G., Covington, T., Gentry, R., and Shipp, A. (2002). Review and evaluation of the potential impact of age and gender-specific pharmacokinetic differences on tissue dosimetry. Crit. Rev. Toxicol.32(5), 329\u2013389.","DOI":"10.1080\/20024091064264"},{"key":"key\n\t\t\t\t20170508185709_R10","doi-asserted-by":"crossref","unstructured":"Gearhart, J. M., Mahle, D. A., Greene, R. J., Seckel, C. S., Flemming, C. D., Fisher, J. W., and Clewell, H. J. (1993). Variability of physiologically-based pharmacokinetic (PB-PK) model parameters and their effects on PB-PK model predictions in a risk assessment for perchloroethylene. Toxicol. Lett.68,131\u2013144.","DOI":"10.1016\/0378-4274(93)90126-I"},{"key":"key\n\t\t\t\t20170508185709_R11","doi-asserted-by":"crossref","unstructured":"Gentry, P. R., Covington, T. R., Andersen, M. E., and Clewell, H. J. (2002). Application of a physiologically-based pharmacokinetic model for isopropanol n the derivation of an RfD\/RfC. Reg. Toxicol. Pharmacol..36,51\u201368.","DOI":"10.1006\/rtph.2002.1540"},{"key":"key\n\t\t\t\t20170508185709_R12","doi-asserted-by":"crossref","unstructured":"Gentry, P. R., Covington, T. R., and Clewell, H. J. (2003). Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Reg. Toxicol. Pharmacol.38(1), 1\u201316.","DOI":"10.1016\/S0273-2300(03)00047-3"},{"key":"key\n\t\t\t\t20170508185709_R13","doi-asserted-by":"crossref","unstructured":"Ginsberg, G. L. (2003). Assessing cancer risks from short-term exposures in children. Risk Anal.23(1), 19\u201334.","DOI":"10.1111\/1539-6924.00287"},{"key":"key\n\t\t\t\t20170508185709_R14","doi-asserted-by":"crossref","unstructured":"Ginsberg, G., Hattis, D., Sonawane, B., Russ, A., Banati, P., Kozlak, M., Smolenski, S., and Goble, R. (2002). Evaluation of child\/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol. Sci.66(2), 185\u2013200.","DOI":"10.1093\/toxsci\/66.2.185"},{"key":"key\n\t\t\t\t20170508185709_R15","doi-asserted-by":"crossref","unstructured":"Guengerich, F., Kim, D., and Iwasaki, M. (1991). Role of cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol.4,168\u2013179.","DOI":"10.1021\/tx00020a008"},{"key":"key\n\t\t\t\t20170508185709_R16","doi-asserted-by":"crossref","unstructured":"Hattis, D., Ginsberg, G., Sonawane, B., Smolenski, S., Russ, A., Kozlak, M., and Goble, R. (2003). Differences in pharmacokinetics between children and adults\u2014II. Children\u2032s variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal.23(1), 117\u2013142.","DOI":"10.1111\/1539-6924.00295"},{"key":"key\n\t\t\t\t20170508185709_R17","unstructured":"International Commission on Radiological Protection (ICRP). (1975). Report of the Task Group on Reference Man. Pergamon Press, Oxford. ICRP Publication 23."},{"key":"key\n\t\t\t\t20170508185709_R18","unstructured":"International Programme on Chemical Safety (IPCS). (2001). Guidance document for the use of data in development of chemical-specific adjustment factors (CSAF) for interspecies differences and human variability in dose\/concentration response assessment World Health Organization, Geneva. Available at: http:\/\/www.ipcsharmonize.org."},{"key":"key\n\t\t\t\t20170508185709_R19","doi-asserted-by":"crossref","unstructured":"Kreuzer, P. E., Csanady, G. A., Baur, C., Kessler, W., Paepke, O., Greim, H., and Filser, J. G. (1997). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition. Arch. Toxicol.71,383\u2013400.","DOI":"10.1007\/s002040050402"},{"key":"key\n\t\t\t\t20170508185709_R20","doi-asserted-by":"crossref","unstructured":"Lipscomb, J., Meek, M. E., Krishnan, K., Kedderis, G. L., Clewell, H. J., and Haber, L. (2004). Incorporation of pharmacokinetic and pharmacodynamic data into risk assessments. Toxicology Mechanisms and Methods,14,1\u201314.","DOI":"10.1080\/15376520490429382"},{"key":"key\n\t\t\t\t20170508185709_R21","doi-asserted-by":"crossref","unstructured":"Mayersohn, M. (1994). Pharmacokinetics in the elderly. Environ. Health Perspect.102,119\u2013124.","DOI":"10.1289\/ehp.94102s11119"},{"key":"key\n\t\t\t\t20170508185709_R22","doi-asserted-by":"crossref","unstructured":"Mendrala, A. L., Langvardt, P. W., Nitschke, K. D., Quast, J. F., and Nolan, R. J. (1993). In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human. Arch. Toxicol.67,18\u201327.","DOI":"10.1007\/BF02072030"},{"key":"key\n\t\t\t\t20170508185709_R23","doi-asserted-by":"crossref","unstructured":"Milsap, R. L., and Jusko, W. J. (1994). Pharmacokinetics in the infant. Environ. Health Perspect.102 (Suppl. 11), 107\u2013110.","DOI":"10.1289\/ehp.94102s11107"},{"key":"key\n\t\t\t\t20170508185709_R24","doi-asserted-by":"crossref","unstructured":"Murphy, J., Janszen, D., and Gargas, M. (1995). An in vitro method for determination of tissue partition coefficients of non-volatile chemicals such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and estradiol. J. Appl. Toxicol.15(2), 147\u2013152.","DOI":"10.1002\/jat.2550150215"},{"key":"key\n\t\t\t\t20170508185709_R25","unstructured":"National Research Council (NRC). (1986). Dose-route extrapolations: Using inhalation toxicity data to set drinking water limits. In Drinking Water and Health. Vol. 6, Chap. 6. National Academy Press, Washington, DC."},{"key":"key\n\t\t\t\t20170508185709_R26","unstructured":"National Health and Nutrition Examination Survey (NHANES). (1995). Third National Health and Nutrition Examination Survey, 1988\u20131991. Selected Laboratory and Mobile Examination Center Data. Version 1, September 1995."},{"key":"key\n\t\t\t\t20170508185709_R27","doi-asserted-by":"crossref","unstructured":"Ogiu, N., Nakamura, Y., Ijiri, I., Hiraiwa, K., and Ogiu, T. (1997). A statistical analysis of the internal organ weights of normal Japanese people. Health Phys.72,368\u2013383.","DOI":"10.1097\/00004032-199703000-00004"},{"key":"key\n\t\t\t\t20170508185709_R28","doi-asserted-by":"crossref","unstructured":"Pacifici, G. M., Boobis, A. R., Brodie, M. J., McManus, M. E., and Davies, D. S. (1981). Tissue and species differences in enzymes of epoxide metabolism. Xenobiotica11,73\u201379.","DOI":"10.3109\/00498258109045276"},{"key":"key\n\t\t\t\t20170508185709_R29","doi-asserted-by":"crossref","unstructured":"Pelekis, M., Gephart, L., and Lerman, S. (2001). Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds. Reg. Toxicol. Pharmacol.33,12\u201320.","DOI":"10.1006\/rtph.2000.1436"},{"key":"key\n\t\t\t\t20170508185709_R30","doi-asserted-by":"crossref","unstructured":"Pikkarainen, P. H., and Ra\u0308iha\u0308, N. C. R. (1967). Development of alcohol dehydrogenase activity in the human liver. Pediatr. Res.1,165\u2013168.","DOI":"10.1203\/00006450-196705000-00001"},{"key":"key\n\t\t\t\t20170508185709_R31","unstructured":"Plunkett, L. M., Turnbull, D., Rodricks, J. V. (1992). Differences between adults and children affecting exposure assessment. In Similarities and Differences Between Children and Adults: Implications for Risk Assessment (P. Guzelian, C. Henry, and S. Olin, Eds.), pp. 79\u201394. ILSI Press, Washington, DC."},{"key":"key\n\t\t\t\t20170508185709_R32","doi-asserted-by":"crossref","unstructured":"Renwick, A., Dorne, J., and Walton, K. (2000). An analysis of the need for an additional uncertainty factor for infants and children. Reg. Toxicol. Pharmacol.31,286\u2013296.","DOI":"10.1006\/rtph.2000.1394"},{"key":"key\n\t\t\t\t20170508185709_R33","doi-asserted-by":"crossref","unstructured":"Robinson, D. E., Balter, N. J., and Schwartz, S. L. (1992). A physiologically based pharmacokinetic model for nicotine and cotinine in man. J. Pharmacokinet. Biopharm.20,591\u2013609.","DOI":"10.1007\/BF01064421"},{"key":"key\n\t\t\t\t20170508185709_R34","doi-asserted-by":"crossref","unstructured":"Rohde, S., Moser, G. A., Papke, O., and McLachlan, M. S. (1999). Clearance of PCDD\/Fs via the gastrointestinal tract in occupationally exposed persons. Chemosphere38(14), 3397\u20133410.","DOI":"10.1016\/S0045-6535(98)00551-7"},{"key":"key\n\t\t\t\t20170508185709_R35","doi-asserted-by":"crossref","unstructured":"Sarangapani, R., Gentry, P. R., Covington, T. R., Teeguarden, J. G., and Clewell, H. J. (2003). Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal. Toxicol.15(10), 987\u20131016.","DOI":"10.1080\/08958370390226350"},{"key":"key\n\t\t\t\t20170508185709_R36","doi-asserted-by":"crossref","unstructured":"Sonnier, M., and Cresteil, T. (1998). Delayed ontogenesis of CYP1A2 in the human liver. Eur. J. Biochem.251,893\u2013898.","DOI":"10.1046\/j.1432-1327.1998.2510893.x"},{"key":"key\n\t\t\t\t20170508185709_R37","doi-asserted-by":"crossref","unstructured":"Treluyer, J. M., Gueret, G., Cheron, G., Sonnier, M., and Cresteil, T. (1997). Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: In-vivo\/in-vitro correlation and inducibility. Pharmacogenetics7,441\u2013452.","DOI":"10.1097\/00008571-199712000-00002"},{"key":"key\n\t\t\t\t20170508185709_R38","unstructured":"U. S. Environmental Protection Agency (USEPA). (1997). Exposure Factors Handbook Volume I: General Factors. Office of Research and Development, Washington, D. C., EPA\/600\/P-95\/002FA."},{"key":"key\n\t\t\t\t20170508185709_R39","doi-asserted-by":"crossref","unstructured":"Vieira, I., Sonnier, M., and Cresteil, T. (1996). Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur. J. Biochem.238,476\u2013483.","DOI":"10.1111\/j.1432-1033.1996.0476z.x"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/79\/2\/381\/16691618\/kfh109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T01:36:33Z","timestamp":1503538593000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article-lookup\/doi\/10.1093\/toxsci\/kfh109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2004,6]]},"published-print":{"date-parts":[[2004,6]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfh109","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}